Gertsenstein M, Lintott L, Nutter L
Curr Protoc. 2025; 5(2):e70109.
PMID: 39999224
PMC: 11856344.
DOI: 10.1002/cpz1.70109.
Abbasi A, Asim M, Dengel A
J Transl Med. 2025; 23(1):153.
PMID: 39905452
PMC: 11796103.
DOI: 10.1186/s12967-024-06013-w.
Shahid A, Zahra A, Aslam S, Shamim A, Ali W, Aslam B
Mol Biotechnol. 2025; .
PMID: 39894889
DOI: 10.1007/s12033-025-01374-z.
Alipanahi R, Safari L, Khanteymoori A
Mol Ther Nucleic Acids. 2024; 35(4):102370.
PMID: 39654539
PMC: 11626815.
DOI: 10.1016/j.omtn.2024.102370.
Haussmann I, Dix T, McQuarrie D, Dezi V, Hans A, Arnold R
Genome Res. 2024; 34(12):2279-2292.
PMID: 39626969
PMC: 11694751.
DOI: 10.1101/gr.279479.124.
The interplay of DNA repair context with target sequence predictably biases Cas9-generated mutations.
Pallaseni A, Peets E, Girling G, Crepaldi L, Kuzmin I, Moor M
Nat Commun. 2024; 15(1):10271.
PMID: 39592573
PMC: 11599590.
DOI: 10.1038/s41467-024-54566-7.
Interpreting CRISPR-Cas12a enzyme kinetics through free energy change of nucleic acids.
Zhang J, Guan X, Moon J, Zhang S, Jia Z, Yang R
Nucleic Acids Res. 2024; 52(22):14077-14092.
PMID: 39588774
PMC: 11662684.
DOI: 10.1093/nar/gkae1124.
A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening.
Cirincione A, Simpson D, Yan W, McNulty R, Ravisankar P, Solley S
Nat Methods. 2024; 22(1):92-101.
PMID: 39562753
PMC: 11725502.
DOI: 10.1038/s41592-024-02502-4.
DeepMEns: an ensemble model for predicting sgRNA on-target activity based on multiple features.
Ding S, Zheng J, Jia C
Brief Funct Genomics. 2024; 24.
PMID: 39528429
PMC: 11735754.
DOI: 10.1093/bfgp/elae043.
Identification of middle cerebral artery stenosis in transcranial Doppler using a modified VGG-16.
Xu D, Li H, Su F, Qiu S, Tong H, Huang M
Front Neurol. 2024; 15:1394435.
PMID: 39479004
PMC: 11521853.
DOI: 10.3389/fneur.2024.1394435.
Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors.
Zhou X, Gao J, Luo L, Huang C, Wu J, Wang X
Commun Biol. 2024; 7(1):1389.
PMID: 39455714
PMC: 11511846.
DOI: 10.1038/s42003-024-07078-5.
Analysis of single-cell CRISPR perturbations indicates that enhancers predominantly act multiplicatively.
Zhou J, Guruvayurappan K, Toneyan S, Chen H, Chen A, Koo P
Cell Genom. 2024; 4(11):100672.
PMID: 39406234
PMC: 11605691.
DOI: 10.1016/j.xgen.2024.100672.
Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines.
Elrick H, Peterson K, Willis B, Lanza D, Acar E, Ryder E
Sci Rep. 2024; 14(1):22626.
PMID: 39349521
PMC: 11443006.
DOI: 10.1038/s41598-024-72418-8.
Codon usage and expression-based features significantly improve prediction of CRISPR efficiency.
Bergman S, Tuller T
NPJ Syst Biol Appl. 2024; 10(1):100.
PMID: 39227603
PMC: 11372048.
DOI: 10.1038/s41540-024-00431-8.
CRISPR-CasRx-mediated disruption of Aqp1/Adrb2/Rock1/Rock2 genes reduces intraocular pressure and retinal ganglion cell damage in mice.
Yao M, Zeng Z, Li S, Zou Z, Chen Z, Chen X
Nat Commun. 2024; 15(1):6395.
PMID: 39080269
PMC: 11289368.
DOI: 10.1038/s41467-024-50050-4.
DeepCRISTL: deep transfer learning to predict CRISPR/Cas9 on-target editing efficiency in specific cellular contexts.
Elkayam S, Tziony I, Orenstein Y
Bioinformatics. 2024; 40(8).
PMID: 39073893
PMC: 11319645.
DOI: 10.1093/bioinformatics/btae481.
CRISPRware: an efficient method for contextual gRNA library design.
Malekos E, Montano C, Carpenter S
bioRxiv. 2024; .
PMID: 38948878
PMC: 11213142.
DOI: 10.1101/2024.06.18.599405.
Machine learning prediction of prime editing efficiency across diverse chromatin contexts.
Mathis N, Allam A, Talas A, Kissling L, Benvenuto E, Schmidheini L
Nat Biotechnol. 2024; .
PMID: 38907037
DOI: 10.1038/s41587-024-02268-2.
Strong association between genomic 3D structure and CRISPR cleavage efficiency.
Bergman S, Tuller T
PLoS Comput Biol. 2024; 20(6):e1012214.
PMID: 38848440
PMC: 11189236.
DOI: 10.1371/journal.pcbi.1012214.
In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model.
Gopalappa R, Lee M, Kim G, Jung E, Lee H, Hwang H
Mol Ther. 2024; 32(7):2190-2206.
PMID: 38796705
PMC: 11286820.
DOI: 10.1016/j.ymthe.2024.05.027.